Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert L Coffman

Showing results (51-60 of 63) with videos related to

Pageof 7
Sort By:
Cancer Discovery|August 30, 2018
SD-101 in Combination with Pembrolizumab in Advanced Melanoma: Results of a Phase Ib, Multicenter StudyAntoni Ribas, Theresa Medina, Shivaani Kummar, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 22, 2002
New IL-17 family members promote Th1 or Th2 responses in the lung: in vivo function of the novel cytokine IL-25Stephen D Hurst, Tony Muchamuel, Daniel M Gorman, et al.
American Journal of Respiratory and Critical Care Medicine|August 19, 2020
A Phase 2a, Double-Blind, Placebo-controlled Randomized Trial of Inhaled TLR9 Agonist AZD1419 in AsthmaIoannis Psallidas, Vibeke Backer, Piotr Kuna, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 4, 2008
CpG oligodeoxynucleotides alter lymphocyte and dendritic cell trafficking in humansW Nicholas Haining, Jeffrey Davies, Holger Kanzler, et al.
Scientific Reports|November 19, 2020
Development of CpG-adjuvanted stable prefusion SARS-CoV-2 spike antigen as a subunit vaccine against COVID-19Tsun-Yung Kuo, Meei-Yun Lin, Robert L Coffman, et al.
DNA and Cell Biology|February 9, 2005
Superior activity of the type C class of ISS in vitro and in vivo across multiple speciesJason D Marshall, Karen L Fearon, Debbie Higgins, et al.
JCI Insight|September 22, 2017
Combination immunotherapy with TLR agonists and checkpoint inhibitors suppresses head and neck cancerFumi Sato-Kaneko, Shiyin Yao, Alast Ahmadi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 25, 2025
Phase 2, Open-Label, Multicenter Study of Nelitolimod in Combination with Pembrolizumab in Anti-PD-1 Treatment-Naive Advanced MelanomaAntoni Ribas, Mohammed M Milhem, Christopher J Hoimes, et al.
Immunity|June 14, 2015
OX40 Ligand Contributes to Human Lupus Pathogenesis by Promoting T Follicular Helper ResponseClément Jacquemin, Nathalie Schmitt, Cécile Contin-Bordes, et al.
Immunity|November 16, 2005
Human TLR-7-, -8-, and -9-mediated induction of IFN-alpha/beta and -lambda Is IRAK-4 dependent and redundant for protective immunity to virusesKun Yang, Anne Puel, Shenying Zhang, et al.
Pageof 7

Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
Cancer Discovery|August 30, 2018
SD-101 in Combination with Pembrolizumab in Advanced Melanoma: Results of a Phase Ib, Multicenter StudyAntoni Ribas, Theresa Medina, Shivaani Kummar, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 22, 2002
New IL-17 family members promote Th1 or Th2 responses in the lung: in vivo function of the novel cytokine IL-25Stephen D Hurst, Tony Muchamuel, Daniel M Gorman, et al.
American Journal of Respiratory and Critical Care Medicine|August 19, 2020
A Phase 2a, Double-Blind, Placebo-controlled Randomized Trial of Inhaled TLR9 Agonist AZD1419 in AsthmaIoannis Psallidas, Vibeke Backer, Piotr Kuna, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 4, 2008
CpG oligodeoxynucleotides alter lymphocyte and dendritic cell trafficking in humansW Nicholas Haining, Jeffrey Davies, Holger Kanzler, et al.
Scientific Reports|November 19, 2020
Development of CpG-adjuvanted stable prefusion SARS-CoV-2 spike antigen as a subunit vaccine against COVID-19Tsun-Yung Kuo, Meei-Yun Lin, Robert L Coffman, et al.
DNA and Cell Biology|February 9, 2005
Superior activity of the type C class of ISS in vitro and in vivo across multiple speciesJason D Marshall, Karen L Fearon, Debbie Higgins, et al.
JCI Insight|September 22, 2017
Combination immunotherapy with TLR agonists and checkpoint inhibitors suppresses head and neck cancerFumi Sato-Kaneko, Shiyin Yao, Alast Ahmadi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 25, 2025
Phase 2, Open-Label, Multicenter Study of Nelitolimod in Combination with Pembrolizumab in Anti-PD-1 Treatment-Naive Advanced MelanomaAntoni Ribas, Mohammed M Milhem, Christopher J Hoimes, et al.
Immunity|June 14, 2015
OX40 Ligand Contributes to Human Lupus Pathogenesis by Promoting T Follicular Helper ResponseClément Jacquemin, Nathalie Schmitt, Cécile Contin-Bordes, et al.
Immunity|November 16, 2005
Human TLR-7-, -8-, and -9-mediated induction of IFN-alpha/beta and -lambda Is IRAK-4 dependent and redundant for protective immunity to virusesKun Yang, Anne Puel, Shenying Zhang, et al.
Pageof 7